27
Views
19
CrossRef citations to date
0
Altmetric
Research Article

The Biochemical and Immunological Properties of Toxic-Shock Syndrome Toxin-1 (Tsst-1) and Association with TSS

&
Pages 1-39 | Published online: 28 Sep 2008

References

  • Todd J., Fishaut M., Kapral F., Welch T. Toxic-Shock Syndrome Associated with Phage Group I Staphylococci. Lancet 1978; 116
  • Stevens F. A. The Occurrence of Stapnylococcus aureus Infection with a Scarlatiniform Rash. J. Am. Med. Assoc. 1927; 8: 957
  • Aranow H., Jr., Wood W. B., Jr. Stapnylococcic Infection Simulatiny Scarlet Fever. J. Am. Med. Assoc. 1942; 11: 491
  • Feldman C. A. Staphylococcal Scarlet Fever. N. Fngl. J. Med. 1361; 26: 77
  • The Royal Commission. The Fatalities at Bundaberg. Med. J. Aust. 1928
  • Shands K. N., Schlech W. F., III, Hargrett N. T., Dan B. B., Schmid G. P., Bennett J. V., Toxic Shock Syndrome Investigation Team. Toxic Shock Syndrome: Case-Control Studies ax the Centers for Disease Control. Ann. Intern. Med. 1982; 9: 95
  • Reingold A., Hargrett N. T., Dan B. B., Shands K. N., Strickland B. Y., Broome C. V. Nonmenstrual Toxic Snock Syndrome: A Review of 130 Cases. Ann. Intern. Med. 1982; 9: 71
  • Davis J. P., Chesney P. J., Wand P. J., LaVenture M., Investigation and Laboratory Team. Toxic-Shock Syndrome: Epidemiologic Features, Recurrence, Risk Factors, and Prevention. N. Engl. J. Med. 1980; 30: 429
  • Shands K. N., Schmid G. P., Dan B. B., Blum D., Guidotti R. J., Hargrett N. T., Anderson R. L., Hill D. L., Broome C. V., Band J. D., Fraser D. W. Toxic-Shock Syndrome in Menstruatinq Women: Its Association with Tampon Use and Staphylococcus aureus and the Clinical Features in 52 Cases. wN. Engl. J. Med. 1980; 31: 31436
  • Minnesota Department of Health. Toxic Shock Syndrome Update. Dis. Control. Newsletter 1980
  • Fisher R. F., Goodpasture H. C., Peterie J. D., Voth D. W. Toxic Shock Syndrome in Menstruating Women. Ann. Intern., Med. 1981; 9: 56
  • Tofte R. W., Williams D. N. Toxic-Shock Syndrome: Clinical and Laboratory Features in 15 Patients. Ann. Intern. Med. 1981; 9: 49
  • McKenna U. G., Meadows J. A., III, Brewer N. S., Wilson W. R., Perrault J. Toxic Shock Syndrome, a Newly Recognized Disease Entity: Report of 11 Cases. May Clin. Proc. 1980; 5: 63
  • Davis J. P., Osterholm M. T., Helms C. M., Vergeront J. M., Wintermeyer L. A., Forfang J. C., Judy L. A., Rondeau J., Schell W. L., the Investigation Team. Tri-State Toxic-Shock Syndrome Stuay. II. Clinical and Laooratory Findings. J. Infect. Dis. 1982; 14: 41
  • Altemeier W. A., Lewis S. A., Schlievert P. M., Bjornson H. S. Studies of Staphylococcal Causation of Toxic-Shock Syndrome. Surg. Gynecol. Obstet. 1981; 15: 81
  • Altemeier W. A., Lewis S. A., Schlievert P. M., Bergdoll M. S., Bjornson H. S., Staneck J. L., Crass B. A. Stapnylococcus aureus Associated with Toxic Shock Syndrome. Phage Typing and Toxin Capability Testing. Ann. Intern. Med. 1982; 9: 78
  • Wallmark G., Finland M. Phage Types and Antibiotic Susceptibility of Patnogenic Stapnylococci. J.A.M.A. 1961; 17: 86
  • Altemeier W. A., Lewis S. A. Cyclic Variation in Emerging Phage Types and Antibiotic Resistance of Staphylococcus aureus. Surgery 1978; 8: 34
  • Vergeront J. M., Stolz S. J., Crass B. A., Nelson D. B., Davis J. P., Bergdoll M. S. Prevalence of Serum Antibody to Staphylococcal Enterotoxin F among Wisconsin Residents, Implications for Toxic-Shock Syndrome. J. Infect. Dis. 1983; 14: 92
  • Arnow P. N., Chou T., Weil D., Crass B. A., Bergdoll M. S. Spread of a Toxic-Shock Syndrome-Associated Strain of Staphylococcus aureus and Measurement of Antibodies to Staphyloccal Enterotoxin F. J. Infect. Dis. 1934; 14: 03
  • Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and Characterization of an Exotoxin from Staphylococcus aureus Associated with Toxic-Shock Syndrome. J. Infect. Dis. 1981; 14: 09
  • Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A New Staphylococcal Enterotoxin, Enterotoxin F, Associated with Toxic-Shock-Syndrome Staphylococcus aureus Isolates. Lancet 1981; 1: 1017
  • Schlievert P. M., Kelly J. A. Stapnylococcal Pyrogenic Exotoxin Type C: Further Characterization. Ann. Intern. Med. 1982; 9: 82
  • Bonventre P. F., Weckbach L., Staneck J., Schlievert P. M., Thompson M. Production of Staphylococcal Enterotoxin F and Pyrogenic Exotoxin C by Staphylococcus aureus Isolates from Toxic Shock Syndrome-Associated Sources. Infect. Immun. 1983; 4: 023
  • Igarashi H., Fujikawa H., Usami H., Kawadata S., Morita T. Purification and Characterization of Staphylococcus-aureus FRI 1169 and 587 Toxic Shock Syndrome Exotoxins. Infect. Immun. 1984; 4: 75
  • Schlievert P. M., Osterholm M. T., Kelly J. A., Nishilmura R. D. Toxin and Enzyme Characterization of Staphylococcus aureus Isolates from Patients with and without Toxic-Shock Syndrome. Ann. Intern. Med. 1982; 9: 37
  • Barbour A. G. Vaginal Isolates of Staphylococcus aureus Associated with Toxic Shock Syndrome. Infect. Immun. 1981; 3: 42
  • Kreiswirtn B. N., Novick R. P., Schlievert P. W., Bergdoll M. Genetic Studies on Stapnylococcal Strains from Patients witn Toxic-Shock Syndrome. Ann. Intern. Med. 1982; 9: 74
  • Todd J. K., Franco-Buff A., I-Awellin D. W., Vasil M. L. Phenotypic Distinctiveness of Staphylococcus aureus Strains Associated with Toxic-Shock Syndrome. Infect. Immun. 1984; 4: 39
  • Kreiswirth B. N., Lofdahl S., Betley M. J., O'Reilly M., Schlievert P. M., Beradoll M. S., Novick R. P. The Toxic Shock Syndrome Exotoxin is not Detectably Transmitted by a Prophage. Nature 1983; 30: 09
  • Cohen M. L., Falkow S. Protein Antigens from Staphylococcus aureus Strains Associated with Toxic-Shock Syndrome. Science 1981; 21: 42
  • Linnemann C. C., Staneck J. L., Hornstein S., Barden T. P., Rauh J. L., Bonventre P. F., Buncher C. R., Beiting A. The Epidemiology of Genital Colonization with) Staphylococcus aureus. Ann. Intern. Med. 1982; 9: 40
  • Davis J. P., Osterholm M. T., Helms C. M., Vergeront J. M., Wintermeyer L. A., Forfang J. C., Judy L. A., Rondeau J., Schell W. L., The Investigation Team. Tri-State Toxic-Shock Syndrome Study: Evaluation of Case Definition and Prevention of Recurrence. Ann. Intern. Med. 1982; 9: 03
  • Ritz H. L., Kirkland J. J., Bond G. G., Warner E. K., Petty G. P. Association and High Levels of Serun Antibody to Staphylococcal Toxic Shock Antigen with Nasal Carriage of Toxic Shock Antigen-Producing Strains of Staphylococcus aureus. Infect. Immun. 1984; 4: 54
  • Bonventre P. F., Linnemann C., Weckbacn L. S., Staneck J. L., Buncher C. R., Vigdortn E., Ritz H., Arcner D., Smith B. Antibody Responses to Toxic-Shock-Syndrome (TSS) Toxin by Patients with TSS ccc Staphylococcal Carriers. J. Infect. Dis. 1984; 15: 62
  • Notermans S., VanLeeuwen W. J., Dufrenne J., Tips P. D. Serum Antibodies to Enterotoxins Produced by Staphylococcus aureus witn Special Reference to Enterotoxin F and Toxic-Shock Syndrome. J. Clin. Microdiol. 1983; 1: 055
  • Center for Disease Control. Follow-up on Toxic-Shock Syndrome. MMWR 1980; 2: 41
  • Ostetrholm M. T., Davis J. P., Gibson R. W., Madel J. S., Wintermeyer L. A., Helms C. M., Forfang J. C., Rondeau J., Vergeront J. M., The Investigation Team. Tri-State Toxic-ShocK Syndrome Study, I. Epidemiologic Findings. J. Infect. Dis. 1982; 14: 31
  • Schlievert P. M., Blomster D. A., Kelly J. A. Toxic-Shock Syndrome Stapnylococcus aureus: Effect of Tampons on Toxic-Snock Syndrome Toxin-1 Production. Obstet. Gynecol. 1984; 6: 66
  • Wagner G., Bohr L., Wagner P. Tampon-Induced Changes in Vaginal Oxygen and Caroon Dioxide Tensions. Am. J. Obstet. Gynecol. 1984; 14: 47
  • Reiser R. F., Robbins R. N., Khoe G. P., Bergdoll M. S. Purification and Physicochemical Properties of Toxic-Shock Toxin. Biochemistry 1983; 2: 907
  • Notermans S., Dufrenne J. B. A Simple Purification Method for Enterotoxin F Produced by Staphylococcus aureus and Some Properties of the Toxin. Antonie van Leeuwenhock 1982; 4: 47
  • Bergdoll M. S., Robbins R. N., Weiss K., Borja C. R., Huang I.-Y., Chu F. S. The Staphylococcal Enterotoxins: Similarities. Contrib. Microbiol. Immunol. 1973; 1: 90
  • Bloomster T. G., Watson D. W. Detection of Microgram Quantities of Carrier Ampholytes in Electrofocused Proteins by Thin-Layer Chromatography. Anal. Biochm. 1981; 11: 9
  • Kreiswirth B. N., Kornblum J. S., Novick R. P. Genotypic Variability of the Toxic Shock Syndrome Exoprotein Determinant. Proceedings of the V International Symposium on Stapnylococci and Staphylococcal Infections, WarsawPoland, August, 1984
  • Schlievert P. M., Kelly J. A. Clindamycin-Inducea Suppression of Toxic-Shock Syndrome-Associated Exotoxin Production. J. Infect. Dis. 1984; 14: 71
  • Recsei P., Kreiswirtn B., O'Reilly M., Schlievert P., Gruss A., Novick R. P. RegulaLioii of Exoprotein Gene Expression by agr. Proceedings of the V International Symposium on Staphylococcl and Staphylococcal Infections, WarsawPoland, August, 1984
  • Kim Y. B., Watson D. W. Biologically Active Endotoxins from Salmonella Mutants Deficient in 0- and R-Polysaccharides and Heptose. J. Bact. 1967; 9: 320
  • Dinarello C. A. Interleukin-1. Rev. Infect. Dis. 1984; 6: 1
  • Ikejima T., Dinarello C. A., Gill M. D., Wolff S. M. Toxic Shock (TS) Strains of Staphylococcus aureus are Potent Induces of Human Leukocyte Pyrogen (LP) and Lymphocyte Activating Factor (LAF). Clin. Res. 1983; 3: 96A
  • Dinarello C. A., Bishai I., Rosenwasser L. J., Coceani F. The Influence of Lipoxygenase Inhibitors on the In Vitro Production of Human Leukocyte Pyrogen and Lymphocyte Activating Factor (Interleukin-1). Int. J. Immunopharmacol. 1984; 3
  • Dinarello C. A., Wolff S. M. Molecular Basis of Fever. Amer. J. Med. 1982; 7: 99
  • Vane J. R. Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs. Nature 1971; 23: 32
  • Schlievert P. M. Biological Properties of Toxic Shock Syndrome Exotoxin. Surv. Synth. Path. Res. 1984; 3: 4
  • Schlievert P. M., Watson D. W. Group A Streptococcal Pyrogenic Exotoxin: Pyrogenicity, Alteration of Blood-Brain Barrier, and Separation of Sites for Pyrogenicity and Enhancement of Lethal Endotoxin Shock. Infect. Immun. 1978; 2: 53
  • Schlievert P. M. Enhancement of Host Susceptibility to Lethal Endotoxin Shock by Staphylococcl Pyrogenic Exotoxin Type C. Infect. Immun. 1982; 3: 23
  • Schlievert P. M. Alteration of Immune Function by Staphylococcal Pyrogenic Exotoxin Type C: Possible Role in Toxic-Shock Syndrome. J. Infect. Dis. 1983; 14: 91
  • Peterson P. K., Schlievert P. M., Conroy W., Kelly J. A., Spika J., Quie P. G. Protection Against Staphylococcal Pyrogenic Exotoxin Type C-Enhanced Endotoxin Lethality With Methylprednisolone and IgG. J. Infect. Dis. 1983; 14: 58
  • Bernheim H. A., Block L. H., Atkins E. Fever: Pathogenesis, Pathophysiology and Purpose. Ann. Intern. Med. 1979; 9: 61
  • Poindexter N. J., Schlievert P. M. Toxic-Shock Syndrome Toxin 1-Induced Proliferation of Lymphocytes: Comparison of the Mitogenic Response of Human, Murine and Rabbit Lymphocytes. J. Infect. Dis. 1985; 15: 5
  • Calvano S. E., Quimby F. W., Antonacci A. C. Analysis of the Mitogenic EFfects of Toxic Shock Antigen on Human Mononuclear Cells In Vitro. Fed. Proc. 1984; 4: 23A
  • Rosenstreich D. L., Farrar J. J., Dougherty S. Absolute Macrophage Dependency of T Lymphocyte Activation by Mitogens. J. Immunol. 1976; 11: 31
  • Cantrell D. A., Smith K. A. The Interleukin-2 T-cell System: A New Cell Model. Science 1984; 22: 312
  • Smith K. A., Lachman L. B., Oppenheim J. J., Favata M. F. The Functional Relationship of the Interleukins. J. Exp. Med. 1980; 15: 551
  • Barsumian E. L., Schlievert P. M., Watson D. W. Nonspecific and Specific Immnunological Mitogenicity by Group A Streptococcal Pyrogenic Exotoxins. Infect. Immun. 1978; 2: 81
  • Poindexter N. J., Schlievert P. M. Toxic Shock Syndrome Exotoxin-Induced Alterations in T lymphocyte Function. Amer. Soc. Microbiol. 1984; B42A
  • Schlievert P. M., Bettin K. M., Watson D. W. Inhibition of Ribonucleic Acid Synthesis by Group A Streptococcal Pyrogenic Exotoxin. Infect. Immun. 1980; 2: 42
  • Quimby F. W., Olstad M., Weiner E. Experimental Toxic Shock Syndrome in Baboons. Fed. Proc. 1984; 4: 50A
  • Melish M. E., Chen F. S., Murata S. M. Quantitative Detection of Toxic Shock Marker Protein in Human and Experimental Toxic Shock Syndrome (TSS). Clin. Res. 1983; 3: 22A
  • Scott D. F., Kling J. M., Kirkland J. J., Best G. K. Characterization of Stahylococcus aureus Isolates from Patients with Toxic Shock Syndrome, Using Polyethylene Infection Chambers in Rabbits. Infect. Immun. 1983; 3: 83
  • Arko R. J., Rasheed J. K., Broome C. V., Chandler F. W., Paris A. C. A Rabbit Model of Toxic Shock Syndrome: Clinicopathological Features. J. Infection 1984; 05
  • Schlievert P. M., Blomster D. A. Production of Staphylococcal Pyrogenic Exotoxin Type C: Influences of Physical and Chemical Factors. J. Infect. Dis. 1983; 14: 36
  • Schlievert P. M., Bettin K. M., Watson D. W. Reinterpretation of the Dick Test: Role of Group A Streptococcal Pyroyenic Exotoxin. Infect. Immun. 1979; 2: 67
  • Kim Y. B., Watson D. W. A Purified Group A Streptococcal Pyrogenic Exotoxin. Physicochemical and Biological Properties Including the Enhancement of Susceptibility to Endotoxin Lethal Shock. J. Exp. Med. 1970; 13: 11
  • Schlievert P. M., Schoettle D. J., Watson D. W. Purificatian and Physicochemical and Biological Characterization of a Staphylococcal Pyrogenic Exotoxin. Infect. Immun. 1979; 2: 09
  • Kapral F. A. Epidermal Toxin Production by Staphylococcus aureus Strains from Patients with Toxic-Shock Syndrome. Science 1982; 21: 42
  • Chow A. W., Gribdle M. J., Bartlett K. H. Hemolytic Activity of Toxic-Shock Syndrome Associated Staphylococcus aureus. J. Infect. Dis. 1982; 14: 8
  • DeSaxe M. J., Weineke A. A., DeAzevedo J., Arbuthnott J. P. Staphylococci Associated with Toxic-Shock Syndrome in the United Kingdoci. Ann. Intern. Med. 1982; 9: 91
  • Parsonnet J., Hickman R. K., Eardley D. D., Pier G. B. Induction of Human Interleukin-1 by Toxic-Shock-Syndrome Toxin-1. J. Infect. Dis. 1985; 15: 14
  • DeAzavedo J. C., Arbuthnott J. P. Toxicity of Staphylococcal Toxic Shock Syndrome Toxin 1 in Rabbits. Infect. Immun. 1984; 4: 14
  • Beisel W. R. Pathophysiology of Staphylococcal Enterotoxin, Type B (SEB) Toxemia After the Intravenous Administration to Monkeys. Toxicon 1972; 1: 33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.